Pharmacologic Actions: News and Research on Anticholesteremic Agents

MeSH tree: D27.505.519.186.071.202

At 85 and healthy? Why more medicine may do more harm

When a patient has made it to 85 years old in reasonable health, their instinct—and often their physician's—is to redouble prevention efforts, optimize every number and close every gap. I want to argue the opposite.

Statin use linked to lower risk of frailty in older veterans

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications ...

The potential problems of living longer: Q&A

Many scientists are trying to determine just how much medical intervention can lengthen the human lifespan. But Daniel Promislow, senior scientist and scientific advisor at the Jean Mayer USDA Human Nutrition Research Center ...

Early action on bad cholesterol delays heart disease

Taking steps to lower levels of harmful LDL cholesterol at a much earlier stage than current medical practice indicates could be a far more effective way to reduce the risk of future heart attacks and strokes, according to ...

Why are medications administered in different forms?

Medications are available and delivered in various forms, including liquids, pills, injections, IV drips, inhalants, and suppositories, to name a few. But what makes one option, otherwise known as a delivery system, better ...

Researchers explore new approach to multivirus drug development

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even better) a broad range of viruses—whatever comes along, in other words. Must be impervious to viral attempts ...

page 1 from 16